Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
J Crit Care ; 57: 231-239, 2020 06.
Article in English | MEDLINE | ID: mdl-32061462

ABSTRACT

The administration of ascorbic acid (vitamin C) alone or in combination with thiamine (vitamin B1) and corticosteroids (VCTS) has recently been hypothesized to improve hemodynamics, end-organ function, and may even increase survival in critically ill patients. There are several clinical studies that have investigated the use of vitamin C alone or VCTS in patients with sepsis and septic shock or are ongoing. Some of these studies have demonstrated its safety and potential benefit in septic patients. However, many questions remain regarding the optimal dosing regimens and plasma concentrations, timing of administration, and adverse effects of vitamin C and thiamine. These questions exist because the bulk of research regarding the efficacy of vitamin C alone or in combination with thiamine and corticosteroids in sepsis is limited to a few randomized controlled trials, retrospective before-and-after studies, and case reports. Thus, although the underlying rationale and mechanistic pathways of vitamin C and thiamine in sepsis have been well described, the clinical impact of the VCTS regimen is complex and remains to be determined. This review aims to explore the current evidence and potential benefits and adverse effects of the VCTS regimen for the treatment of sepsis.


Subject(s)
Ascorbic Acid/therapeutic use , Hydrocortisone/therapeutic use , Sepsis/drug therapy , Thiamine/therapeutic use , Adrenal Cortex Hormones/therapeutic use , Ascorbic Acid Deficiency/drug therapy , Clinical Protocols , Critical Illness , Dietary Supplements , Hemodynamics , Humans , Intestines/drug effects , Patient Safety , Randomized Controlled Trials as Topic , Retrospective Studies , Sepsis/mortality , Shock, Septic/mortality , Vitamins/therapeutic use
2.
Asian Pac J Cancer Prev ; 20(3): 951-960, 2019 Mar 26.
Article in English | MEDLINE | ID: mdl-30912420

ABSTRACT

Objective: In recent years, citation analysis tools provide many devices for finding or computing the citation score or impact factor for journals. It is important for the researchers to identify good journals for collecting research ideas discussed. A journal with a good impact factor value is preferably referred to by many researchers. In this research work, the author proposes a system for ranking journals on the basis of ideas and results cited in other papers. Methods: The work involves the cited content extractor for extracting the descriptive features mentioned about the cited paper. The cited content refers to the content in the article written by a citing paper and relating to the cited paper. The ranking system uses a citation score estimator for computing the overall weight of the descriptive cited content relating to a specific paper in the citing papers. The journal ranking system performs classification of the citation content with the evaluation of a citation score. The work that involves the citation content is classified under different categories as positively cited, negatively cited or neutral and unrelated. Results: Then the computed citation score is used for ranking the dealing with research on cancer research journals. The results of the ranking journals indicate that the particular ranked journal has been cited in the literature of many journals with a good descriptive content. Journal ranking system can be considered as a well-organized tool for ranking the cancer research scientific journal based on citation content and citation counting. Conclusion: This experimental cancer journal ranking method increases accuracy and effectiveness by using the citation content when compared with PageRank and HITS.


Subject(s)
Algorithms , Biomedical Research , Data Mining/statistics & numerical data , Database Management Systems , Information Storage and Retrieval/methods , Neoplasms/pathology , Periodicals as Topic , Humans , Natural Language Processing , PubMed , Vocabulary, Controlled
3.
J Chromatogr Sep Tech ; 7(5)2016 Oct.
Article in English | MEDLINE | ID: mdl-27833786

ABSTRACT

A simple and sensitive method for the detection of methylmalonic acid in serum without derivatization has been developed. This method implements protein precipitation using methanol followed by additional sample clean up by turbulent flow liquid chromatography (TFLC). The sample was directly injected into the turbulent flow liquid chromatography tandem mass spectrometry system (TFLC-MS/MS) for online extraction followed by HPLC separation. The eluent was transferred to the mass spectrometer and ionized by heated electrospray negative ionization (HESI) and the analyte was quantified using a six-point calibration curve. The validated analytical measurement range (AMR) is 30-1,000 nMol/L. Dilutions of 10 and 200-fold were validated giving a clinical reportable range (CRR) of 30-200,000 nMol/L. The between-day and within-day imprecision values at concentrations spanning the AMR were less than 15%. This method was compared to an established LC-MS/MS method at a CLIA certified national reference laboratory and shows an excellent correlation with our TFLC-MS/MS method.

4.
Res Pharm Sci ; 8(2): 125-36, 2013 Apr.
Article in English | MEDLINE | ID: mdl-24019822

ABSTRACT

Candesartan cilexetil (CC) is a newer class of angiotensin II receptor antagonist used for the treatment of hypertension. The solubility of the CC is very poor and its oral bioavailability is only 15%. The controlledrelease polar lipid microparticles of CC (formulations F1, F2, F3 and F4) were prepared using variable erodible lipophilic excipients like hydrogenated castor oil, stearic acid, cetostearyl alcohol and carnauba wax by fusion method. The particle sizes of polar lipid microparticles were less than 50 microns and they were irregular in shape. Drug content ranged between 98.96 ± 2.1 and 101.9 ± 1.6% were present in all the formulations. The formulation F3 showed better drug release throughout the study period in a controlled release manner. Moreover, the in vitro release showed that all the formulations were best fitted to Higuchi model. Accelerated stability studies indicated that there was no significant changes in the chemical and physical characteristics of the formulated drug product during initial and at the end of the study period. The FTIR and DSC studies showed that there was no interaction between the drug and lipophilic excipients and no polymorphic transitions in all formulations. The X-ray diffraction peak of solid dispersion indicated that the crystalline nature of CC disappeared and no new peaks could be observed, suggesting the absence of interaction between drug and excipients.

5.
Clin Ter ; 161(3): 249-52, 2010.
Article in English | MEDLINE | ID: mdl-20589356

ABSTRACT

AIM: The plantaris muscle (PM) and its tendon is subject to considerable variation in both the points of origin and of insertion. The present study was carried out to fi nd the different types of origin, insertion and possible variations of the PM in the population of southern costal region of India. MATERIALS AND METHODS: 52 embalmed (Formalin fixed) cadaver lower limbs of 26 males (age ranged 48-79 years, mean age 68 years) were dissected, to study the origin and insertion of PM. Various dimensions (length and width) of plantaris muscle belly and its tendon were also measured. RESULTS: Three types of origin and equal number of insertion were noticed in the present study. The PM took origin from type I: Lateral Supracondylar ridge, Capsule of Knee joint and Lateral head of gastrocnemius in 73.07% cases; type II: Capsule of Knee joint and Lateral head of gastronemius in 5.76% cases; type III: Lateral Supracondylar ridge , Capsule of Knee joint , Lateral head of gastrocnemius and fibular collateral ligament in 13.46% cases. The plantaris tendon was inserted into type I: to the flexor retinaculum of foot in 28.84% cases; type II: independently to the os calcaneum in 36.53% cases; type III: to the tendocalcaneus at various levels in 26.92% cases. In four lower limbs (7.69%) the plantaris muscle was completely absent. Additionally the length and width of the plantaris muscle and its tendon were measured to know any side difference. There were no statistically significant differences between the measurements of left and right side (p>0.05). CONCLUSION: Present study will help the surgeons while attempting various surgical procedures in and around the posterior aspect of knee involving plantaris.


Subject(s)
Muscle, Skeletal/anatomy & histology , Adult , Aged , Cadaver , Female , Humans , India , Male , Middle Aged
6.
Singapore Med J ; 48(8): e231-3, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17657373

ABSTRACT

Anomalous muscles usually do not cause symptoms but are of academic interest. They become a surgical problem when they produce symptoms or are difficult to differentiate from soft tissue tumours. During routine cadaveric dissection for the undergraduate students at the Kasturba Medical College, Mangalore, we came across two additional muscles in the deep flexor compartment of the right forearm of a 69-year-old woman. The anomalous muscles were located on the ventral aspect of the proximal forearm, in a plane deep to the flexor digitorum superficialis (FDS). Both the muscles originated from the deep surface of the FDS. The muscle on the radial side was a Gantzer's muscle as it was inserted into the tendon of the flexor pollicis longus. The muscle on the ulnar side formed an independent tendon for the middle finger, 14 cm above the proximal edge of the flexor retinaculum and passed through the carpal tunnel; surprisingly the tendon of the additional muscle and flexor digitorum profundus tendon for the middle finger gave origin to the second lumbrical in the carpal tunnel. The passive traction on the tendon of the additional muscle resulted in flexion of the distal and medial phalanges. The presence of such an additional tendon and origin of lumbrical muscle in the carpal tunnel should be considered in the aetiology of carpal tunnel syndrome.


Subject(s)
Muscle, Skeletal/abnormalities , Aged , Cadaver , Female , Forearm , Humans , Tendons/abnormalities
7.
Biophys Chem ; 101-102: 239-47, 2002 Dec 10.
Article in English | MEDLINE | ID: mdl-12488004

ABSTRACT

Removal of the N-terminal formyl group from newly synthesized proteins by the enzyme peptide deformylase (PDF) is essential for normal growth of bacteria but not higher organisms. Recently, PDF has been explored as a target for novel antibiotics. Screening a collection of natural products for antimicrobial activity identified actinonin and two matlystatin analogs as potent PDF inhibitors. A number of synthetic analogs of these natural products were prepared and their inhibitory potency determined. Previous work has shown that PDF is an iron metalloproteinase also containing a catalytic glutamic acid residue. Ligation of the ferrous cation is an essential feature of potent inhibitors. The structures of actinonin, a matlystatin analog and a synthetic inhibitor complexed with PDF were determined by crystallography. A quantum mechanics/molecular mechanics (QM/MM) method was used to reproduce the geometry of known complexes, to predict the protonation state in the active site and to predict the geometry of additional complexes. The requirement for protonation of the active site glutamate anion is an important factor in understanding the potency of inhibitors with acidic iron-ligating groups such as hydroxamate and carboxylate. Even though potent inhibitors of PDF have been discovered, their bacteriostatic mechanism of action and the rapid development of resistance in vitro may limit their potential as antibacterial drugs.


Subject(s)
Amidohydrolases , Aminopeptidases/antagonists & inhibitors , Enzyme Inhibitors/metabolism , Metals/metabolism , Enzyme Inhibitors/chemistry , Ligands , Metals/chemistry , Models, Molecular
8.
J Mol Biol ; 305(5): 1099-110, 2001 Feb 02.
Article in English | MEDLINE | ID: mdl-11162117

ABSTRACT

The backbone assignments, secondary structure, topology, and dynamics of the single-chain hepatitis C virus NS3 protease NS4A cofactor complex have been determined by NMR spectroscopy. Residues I34 to S181 of NS3 and the central three residues of the NS4A cofactor were assigned and the secondary structure was verified for these residues. In several X-ray structures of NS4A-bound NS3 protease, residues 1 to 28 are stabilized by crystal packing, which allows for the formation of the A0 strand and alpha0 helix. In solution, these N-terminal residues are largely unassigned and no evidence of a well-structured A0 strand or alpha0 helix was detected. NOEs between residues in the E1-F1 loop (containing D81) and the alpha1 helix (containing H57) together with the detection of a D81-H57 hydrogen bond indicate that in solution the catalytic triad (D81, H57, S139) of the protease is better ordered in the presence of the NS4A cofactor. This is consistent with the earlier crystallographic results and may explain the observed increase in catalytic activity of the enzyme due to NS4A binding. A model-free analysis of our relaxation data indicates substantial exchange rates for residues V51-D81, which comprise the upper part of the N-terminal beta-barrel. A comparison of chemical-shift differences between NS3 protease and the NS3 protease-NS4A complex shows extensive chemical-shift changes for residues V51-D81 indicating that non-local structural changes occur upon NS4A binding to the NS3 protease that are propagated well beyond the protease-cofactor interaction site. This is consistent with crystallographic data that reveal large structural rearrangements of the strand and loop regions formed by residues V51-D81 as a result of NS4A binding. The coincidence of large exchange rates for the NS3 protease-NS4A complex with chemical-shift differences due to NS4A binding suggests that residues V51-D81 of the NS3 protease NS4A complex are in slow exchange with a NS4A-free conformation of NS3 protease.


Subject(s)
Coenzymes/chemistry , Coenzymes/metabolism , Hepacivirus/chemistry , Viral Nonstructural Proteins/chemistry , Viral Nonstructural Proteins/metabolism , Binding Sites , Hepacivirus/enzymology , Macromolecular Substances , Models, Molecular , Nuclear Magnetic Resonance, Biomolecular , Protein Binding , Protein Structure, Secondary , RNA Helicases , Serine Endopeptidases , Solutions
9.
Neuron ; 27(3): 469-74, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11055430

ABSTRACT

Murine and canine narcolepsy can be caused by mutations of the hypocretin (Hcrt) (orexin) precursor or Hcrt receptor genes. In contrast to these animal models, most human narcolepsy is not familial, is discordant in identical twins, and has not been linked to mutations of the Hcrt system. Thus, the cause of human narcolepsy remains unknown. Here we show that human narcoleptics have an 85%-95% reduction in the number of Hcrt neurons. Melanin-concentrating hormone (MCH) neurons, which are intermixed with Hcrt cells in the normal brain, are not reduced in number, indicating that cell loss is relatively specific for Hcrt neurons. The presence of gliosis in the hypocretin cell region is consistent with a degenerative process being the cause of the Hcrt cell loss in narcolepsy.


Subject(s)
Brain/pathology , Carrier Proteins , Intracellular Signaling Peptides and Proteins , Narcolepsy/pathology , Neurons/pathology , Neuropeptides , Neurotransmitter Agents/metabolism , Adult , Aged , Aged, 80 and over , Astrocytes/metabolism , Astrocytes/pathology , Brain/metabolism , Cell Count , Female , Glial Fibrillary Acidic Protein/metabolism , Gliosis/pathology , Humans , Hypothalamic Hormones/metabolism , Hypothalamus/metabolism , Hypothalamus/pathology , Immunohistochemistry , Male , Melanins/metabolism , Middle Aged , Narcolepsy/etiology , Neurons/metabolism , Orexins , Pituitary Hormones/metabolism
10.
Biochem Biophys Res Commun ; 267(1): 278-82, 2000 Jan 07.
Article in English | MEDLINE | ID: mdl-10623610

ABSTRACT

The NS3 serine protase of Hepatitis C virus (HCV) requires NS4A protein as a cofactor for efficient cleavage at four sites in the nonstructural region. The cofactor activity has been mapped to the central hydrophobic region (aa 22-34) of this 54-amino-acid NS4A protein, and site-directed mutagenesis has identified alternating hydrophobic amino acids, particularly Ile25 and Ile29, as critically important. A double mutant of NS4A cofactor peptide, I25A/I29A, completely abolished the cofactor activity. We now report that the cofactor peptide activity in the I25A/I29A double mutant can be restored specifically by introducing a biotin-aminohexanoic acid fusion at the N-terminus. In addition, a similar N-terminal fusion of biotin-aminohexanoic acid with the wild-type 4A peptide significantly enhanced cofactor activity. Our data corroborate the crystal structure-based hypothesis of hydrophobic interaction between the N-terminus of NS4A and the N-terminal alpha(0) helix of NS3 protease.


Subject(s)
Hepacivirus/enzymology , Peptide Fragments/metabolism , Viral Nonstructural Proteins/chemistry , Viral Nonstructural Proteins/metabolism , Amino Acid Sequence , Amino Acid Substitution , Biotinylation , Cloning, Molecular , Models, Molecular , Molecular Sequence Data , Mutagenesis, Site-Directed , Peptide Fragments/chemical synthesis , Peptide Fragments/chemistry , Protein Biosynthesis , Protein Conformation , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Serine Endopeptidases/chemistry , Serine Endopeptidases/metabolism , Viral Nonstructural Proteins/genetics
11.
Biochemistry ; 37(10): 3392-401, 1998 Mar 10.
Article in English | MEDLINE | ID: mdl-9521660

ABSTRACT

Hepatitis C virus (HCV) protease NS3 and its protein activator NS4A participate in the processing of the viral polyprotein into its constituent nonstructural proteins. The NS3/4A complex is thus an attractive target for antiviral therapy against HCV. We expressed the full-length NS3 and NS4A in insect cells as a soluble fusion protein with an N-terminal polyhistidine tag and purified the two proteins to homogeneity. Cleavage at the junction between HisNS3 and NS4A occurs during expression, producing a noncovalent complex between HisNS3 and NS4A with a subnanomolar dissociation constant. We purified the HisNS3/4A complex by detergent extraction of cell lysate and by metal chelate chromatography. We removed the His tag by thrombin cleavage and then further purified the complex by gel filtration. The purified NS3/4A complex is active in a protease assay using a synthetic peptide substrate derived from the NS5A-NS5B junction, with kcat/K(m) of 3700 (+/- 600) M-1 s-1, an order of magnitude above those previously reported for NS3 expressed by other strategies. This high protease activity implies that the full-length sequences of NS3 and NS4A are required for optimal activity of the NS3 protease domain. We examined the dependence of the NS3/4A protease activity on buffer conditions, temperature, and the presence of detergents. We find that, under most conditions, NS3 protease activity is dependent on the aggregation state of the NS3/4A complex. The monodisperse, soluble form of the NS3/4A complex is associated with the highest protease activity.


Subject(s)
Hepacivirus/enzymology , Hepacivirus/genetics , Serine Endopeptidases/genetics , Viral Nonstructural Proteins/genetics , Adenosine Triphosphatases/metabolism , Amino Acid Sequence , Animals , Baculoviridae/genetics , Cell Line , Cloning, Molecular , DNA Helicases/metabolism , Gene Expression , Genes, Viral , Kinetics , Molecular Sequence Data , Protein Structure, Secondary , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/metabolism , Serine Endopeptidases/isolation & purification , Serine Endopeptidases/metabolism , Spodoptera , Viral Nonstructural Proteins/isolation & purification , Viral Nonstructural Proteins/metabolism
12.
J Virol ; 71(8): 6208-13, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9223519

ABSTRACT

We probed the substrate specificity of a recombinant noncovalent complex of the full-length hepatitis C virus (HCV) NS3 serine protease and NS4A cofactor, using a series of small synthetic peptides derived from the three trans-cleavage sites of the HCV nonstructural protein sequence. We observed a distinct cleavage site preference exhibited by the enzyme complex. The values of the turnover number (k(cat)) for the most efficient NS4A/4B, 4B/5A, and 5A/5B peptide substrates were 1.6, 11, and 8 min(-1), respectively, and the values for the corresponding Michaelis-Menten constants (Km) were 280, 160, and 16 microM, providing catalytic efficiency values (k(cat)/Km) of 92, 1,130, and 8,300 M(-1) s(-1). An alanine-scanning study for an NS5A/5B substrate (P6P4') revealed that P1 Cys and P3 Val were critical. Finally, substitutions at the scissile P1 Cys residue by homocysteine (Hcy), S-methylcysteine (Mcy), Ala, S-ethylcysteine (Ecy), Thr, Met, D-Cys, Ser, and penicillamine (Pen) produced progressively less efficient substrates, revealing a stringent stereochemical requirement for a Cys residue at this position.


Subject(s)
Peptides/metabolism , Serine Endopeptidases/metabolism , Viral Nonstructural Proteins/metabolism , Amino Acid Sequence , Kinetics , Molecular Sequence Data , Substrate Specificity
13.
Virology ; 225(2): 328-38, 1996 Nov 15.
Article in English | MEDLINE | ID: mdl-8918919

ABSTRACT

The NS3 proteinase of hepatitis C virus utilizes NS4A as a cofactor for cleavages at four sites (3/4A, 4A/4B, 4B/5A, and 5A/5B) in the nonstructural region of the viral polyprotein. To characterize NS4A for its role in modulating the NS3 proteinase activity at various cleavage sites, synthetic peptides spanning various parts of NS4A were synthesized and tested in a cell-free trans-cleavage reaction using purified NS3 proteinase domain and polyprotein substrates. The NS3 proteinase domain was expressed in Escherichia coli, purified, denatured, and refolded to an enzymatically active form. We found that a 12-amino-acid peptide containing amino acid residues 22 to 33 in NS4A (CVVIVGRIVLSG) was sufficient for cofactor activity in NS3-mediated proteolysis. The peptide enhanced the cleavage at the NS5A/5B site and was necessary for NS3-mediated cleavage at NS4A/4B and NS4B/5A. Sequential amino acid substitution within the designated peptide identified residues I29 and I25 as critical for potential cofactor activity. We provide evidence that the NS4A peptide and the NS3 catalytic domain form an enzymatically active complex. These data suggest that the central 12-amino-acid peptide (aa 22-33) of NS4A is primarily important for the cofactor activity through complex formation with NS3, and the interaction may represent a new target for antiviral drug development.


Subject(s)
Hepacivirus/metabolism , Peptides/metabolism , Viral Nonstructural Proteins/metabolism , Amino Acid Sequence , Binding Sites , Enzyme Activation , Humans , Molecular Sequence Data , Peptides/chemistry , Peptides/genetics , RNA Helicases , Sequence Analysis , Serine Endopeptidases , Viral Nonstructural Proteins/chemistry , Viral Nonstructural Proteins/genetics
14.
Protein Eng ; 9(7): 623-8, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8844835

ABSTRACT

The X-ray crystal structure of a rat monoclonal Fab JES1-39D10, raised against recombinant human interleukin-5, has been determined with the use of molecular replacement techniques and refined at 2.7 A resolution by simulated annealing. The overall structure is similar to a murine Fab HyHEL-10 that is specific for hen egg white lysozyme. An interesting feature of the structure is the presence of leucine residues to support the H1 complementarity-determining region (CDR) loop. To our knowledge this is the first Fab crystal structure containing this unusual H1 loop support pattern. The activity of three humanized versions of 39D10 is explained by analysis of Fv interface residues and H1 support patterns of 39D10 and the human template HIL.


Subject(s)
Antibodies, Monoclonal/chemistry , Immunoglobulin Fab Fragments/chemistry , Interleukin-5/immunology , Amino Acid Sequence , Animals , Antibodies, Monoclonal/genetics , Antibody Specificity , Cloning, Molecular , Crystallography, X-Ray , Humans , Immunoglobulin Fab Fragments/genetics , Models, Molecular , Molecular Sequence Data , Protein Conformation , Rats , Species Specificity
15.
Biol Trace Elem Res ; 40(1): 59-70, 1994 Jan.
Article in English | MEDLINE | ID: mdl-7511921

ABSTRACT

Fish phospholipid liposomes were prepared and used as an artificial membrane system to study factors influencing lipid oxidation. The extent of lipid oxidation was indexed by measuring the amount of thiobarbituric acid reactive substances (TBARS) produced. Fe2+, Fe3+, and Cu2+ were potent prooxidants in catalysing lipid oxidation. These metal ions induced lipid oxidation in a dose dependent manner. However, Zn2+, Ni2+, and Mn2+ did not significantly (p > 0.05) affect lipid oxidation at all the concentrations (1, 10, or 100 microM) studied. Morin, luteolin (flavonoids), butein (chalcone), tannic acid, ellagic acid (polyphenols), butylated hydroxyanisole (BHA), and butylated hydroxytoluene (BHT) (synthetic antioxidants) were potent antioxidants (producing < 50% TBARS compared to control) of Fe(2+)-catalyzed lipid oxidation. Morin, luteolin, and butein possess two hydroxyl substituents, a C4 ketone structure and a 2-3 double bond, all of which contributed to their antioxidative potential. Fe2+ caused some losses of polyunsaturated fatty acids (PUFA), whereas tannic acid protected the oxidation of several of the PUFA including C 16:1 (Palmitoleic acid), C 18:3 (Linolenic acid), C 20:4 (Arachidonic acid), C 20:5 (Eicosapentaenoic acid), and C 22:6 (Docosahexaenoic acid).


Subject(s)
Antioxidants/pharmacology , Fishes/metabolism , Lipid Metabolism , Lipid Peroxidation , Liposomes/metabolism , Animals , Copper/pharmacology , Fatty Acids/metabolism , Fatty Acids, Unsaturated/metabolism , Ferric Compounds/pharmacology , Ferrous Compounds/pharmacology , Lipid Peroxidation/drug effects , Oxidation-Reduction , Thiobarbituric Acid Reactive Substances/metabolism
16.
Biochemistry ; 32(14): 3549-56, 1993 Apr 13.
Article in English | MEDLINE | ID: mdl-7682108

ABSTRACT

Human interleukin 4 is a highly pleiotropic cytokine secreted by activated T cells that exerts multiple biological effects on B and T lymphocytes and other cell types. Elucidation of structure-function relations was accomplished by epitope mapping of a panel of monoclonal antibodies and by mutagenesis of selected amino acid residues. Epitope mapping of these monoclonal antibodies was achieved through binding studies with recombinant human interleukin 4 (rhuIL-4), proteolytic fragments produced by digestion with Staphylococcus aureus V8 protease and synthetic peptides derived from the sequence of the parent molecule. Monoclonal antibodies 25D2, 35F2, and 11B4 neutralized the in vitro T-cell proliferation activity of rhuIL-4 and also prevented binding of rhuIL4 to its cell surface receptor. These antibodies recognized sequences 104-129, 70-92, and 61-82, respectively. These regions comprise the BC loop/helix C (residues 61-92) and helix D (residues 104-129). A nonneutralizing monoclonal antibody (1A2) recognized a nonoverlapping region (residues 43-59) comprising almost entirely helix B. Mutagenesis of a cluster of residues within helix C showed that at least three residues (K84, R88, and N89) were potentially involved in receptor recognition. The existence of two distinct nonneighboring binding domains in the three-dimensional structure of rhuIL-4 provided preliminary evidence for a model of receptor interaction involving the formation of a ternary complex consisting of two molecules of the extracellular portion of the receptor and one molecule of rhuIL-4.


Subject(s)
Epitopes/chemistry , Interleukin-4/chemistry , Peptide Mapping , Antibodies, Monoclonal , Blotting, Western , Humans , Interleukin-4/genetics , Interleukin-4/immunology , Models, Molecular , Molecular Structure , Mutagenesis , Peptide Fragments/chemistry , Peptide Fragments/immunology , Peptide Fragments/metabolism , Protein Structure, Secondary , Recombinant Proteins/metabolism , Serine Endopeptidases/metabolism , Structure-Activity Relationship , X-Ray Diffraction
17.
Biol Trace Elem Res ; 34(1): 35-44, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1382520

ABSTRACT

Divalent metal ions (Fe2+, Cu2+, Zn2+, Ni2+, and Mn2+) induced lipid oxidation in cooked, but not in raw fish. The extent of lipid oxidation, measured by the production of thiobarbituric acid reactive substances (TBRS), was increased with higher concentrations of iron, zinc, and nickel, but was decreased with increasing concentrations of copper and manganese. The natural products: ellagic acid, tannic acid, myricetin, and quercetin, inhibited lipid oxidation in cooked fish. The enhanced lipid oxidation caused by cupric ions (10(3) pmol/100 g fish) was also inhibited by the natural products. The degree of inhibition in copper-treated fish, however, was less than that in fish that had no added copper. The inhibition was concentration dependent. The antioxidative potency of the various natural products was independent of the type of metal ion-induced lipid oxidation. Ellagic acid was the most potent antioxidant (75.7-83.9%), followed by tannic acid (60.4-77.3%), myricetin (52.9-70.4%), and quercetin (32.6-44.2%).


Subject(s)
Fish Products/analysis , Hot Temperature , Lipid Peroxidation/drug effects , Metals/pharmacology , Animals , Dose-Response Relationship, Drug , Fishes/metabolism , Iron/pharmacology , Nickel/pharmacology , Zinc/pharmacology
18.
Biochemistry ; 30(40): 9576-82, 1991 Oct 08.
Article in English | MEDLINE | ID: mdl-1911743

ABSTRACT

Human interleukin 4 is a 129 amino acid lymphokine secreted by activated T cells that exerts pleiotropic biological effects on B and T lymphocytes and other hematopoietic cells. Structure-function relations were studied by employing selective proteolytic cleavage of purified recombinant human interleukin 4 (rhuIL-4). Limited proteolysis with endoprotease Glu-C from Staphylococcus aureus (V8) produced two digestion products that were observed on sodium dodecyl sulfate-polyacrylamide gel electrophoresis with apparent molecular weight values of 19K (I) and 15K (II), respectively. These species were isolated by reversed-phase HPLC. Amino acid sequencing indicated that species II was an 84 amino acid core fragment extending from Gln-20 to Glu-103 and containing a hydrolyzed peptide bond at Glu-26. On the basis of known disulfide bond assignments, it was concluded that species II was stabilized by two disulfide bonds (Cys-24/Cys-65 and Cys-46/Cys-99). Analysis of its secondary structure by circular dichroism revealed a high content of alpha helix. Species I was the full-length rhuIL-4 with selective cleavage at Glu-26 and Glu-103. Both species I and II were inactive in an in vitro assay based on proliferation of peripheral blood lymphocyte blasts and lacked the ability to bind to teh rhuIL-4 receptor on Daudi cells. In order to elucidate further the role of the residues removed by S. aureus V8 protease, rabbit antisera were raised to synthetic peptides corresponding to residues 1-26 at the N-terminus and 104-129 at the C-terminus. Only antisera directed to the C-terminal peptide inhibited binding of 125I-rhuIL-4 to Daudi cells.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Interleukin-4/metabolism , Receptors, Mitogen/metabolism , Recombinant Proteins/metabolism , Serine Endopeptidases , Amino Acid Sequence , Animals , Cell Line , Circular Dichroism , Cricetinae , Cricetulus , Electrophoresis, Polyacrylamide Gel , Female , Humans , Hydrolysis , Immune Sera/chemistry , Molecular Sequence Data , Ovary , Peptide Fragments/chemistry , Peptide Fragments/immunology , Peptide Fragments/isolation & purification , Receptors, Interleukin-4 , Receptors, Mitogen/immunology , Recombinant Proteins/immunology , Sodium Dodecyl Sulfate , Staphylococcus aureus
19.
Biochim Biophys Acta ; 1007(3): 283-8, 1989 Apr 12.
Article in English | MEDLINE | ID: mdl-2784692

ABSTRACT

Recombinant murine interleukin-4 (muIL-4) expressed in COS-7 monkey kidney cells was purified to homogeneity by sequential CM-Sepharose, Sephadex G-100 chromatography and mono-S FPLC to a specific activity of 6.10(7) units per mg of protein based on an in vitro HT-2 cell proliferation assay. Two electrophoretic variants, designated a and b, which migrated on SDS-PAGE as a closely spaced doublet with Mr 19,000, were present in the final product. Gas phase sequencing of the purified protein revealed the presence of an N-terminus corresponding to the mature protein predicted from the cDNA sequence and sequencing of a cyanogen bromide digest confirmed 75 of the 120 predicted amino acids. Elution behavior on gel filtration corresponded to that of a monomer of Mr 19,000. Since there are three potential sites of N-glycosylation predicted by the cDNA sequence, the contribution of glycosylation to the observed heterogeneity was examined by treatment with endoglycosidases. Variant b was digested by either endo-beta-N-acetylglucosaminidase H (endo H) or endo-beta-N-acetylglucosaminidase F (endo F) to protein of Mr 15,000 on SDS-PAGE but was unaffected by treatment with endo-beta-N-acetylglucosaminidase D (endo D), thus indicating the presence of high mannose type of N-glycan. In contrast, variant a was resistant to endo H, F and D. Complete conversion of a mixture of variants a and b to a single protein of Mr 15,000 on SDS-PAGE was obtained only after treatment with N-glycanase. Both variants were resistant to neuraminidase and O-glycanase treatment. These data show that the microheterogeneity observed in purified muIL-4 preparations is due to differences in the nature of the N-linked oligosaccharides. The availability of purified recombinant muIL-4 and a methodology for both total and selective deglycosylation provides a basis for the initiation of structure-function studies of this novel T-cell lymphokine.


Subject(s)
Interleukins/genetics , Amino Acid Sequence , Animals , Blotting, Western , Chlorocebus aethiops , Glycoside Hydrolases/pharmacology , Glycosylation , Interleukin-4 , Interleukins/isolation & purification , Mice , Molecular Sequence Data , Molecular Weight , Protein Processing, Post-Translational , Recombinant Proteins/isolation & purification
20.
J Biol Chem ; 263(22): 10817-23, 1988 Aug 05.
Article in English | MEDLINE | ID: mdl-3260592

ABSTRACT

We have purified recombinant human interleukin 4 (huIL-4), formerly named B-cell stimulatory factor-1, from supernatants of COS-7 monkey kidney and L-929 cells transfected with the cDNA for huIL-4. The purified protein exhibited a specific activity of 2.6 X 10(7) units/mg in a T-cell proliferation assay and consisted of multiple components on sodium dodecyl sulfate-polyacrylamide gel electrophoresis exhibiting Mr values of 15,000, 18,000, and 19,000. All forms of huIL-4 eluted on gel filtration chromatography with an apparent Mr of 22,000. Gas-phase microsequencing identified 26 and 8 amino acid residues at the N and C termini, respectively, all of which were consistent with the cDNA sequence. The site of processing of the signal sequence was found to occur between Gly-24 and His-25. Incubation with N-glycanase converted the 18- and 19-kDa variants to a 15-kDa form. Treatment with endo-beta-N-acetylglucosaminidase H reduced the molecular mass of the 18-kDa variant to 15 kDa, but did not have any apparent effects on the mass of the 19-kDa species. The removal of oligosaccharide by any of these treatments did not affect bioactivity in the T-cell proliferation assay. Neither O-glycanase nor endo-beta-N-acetylglucosaminidase D affected the molecular weight of any of these species. These data suggest that differences in carbohydrate structure account, at least in part, for the observed microheterogeneity.


Subject(s)
Genetic Variation , Interleukins/genetics , Recombinant Proteins/isolation & purification , Transfection , Amino Acid Sequence , Animals , B-Lymphocytes/immunology , Cell Line , DNA/genetics , Electrophoresis, Polyacrylamide Gel , Humans , Interleukin-4 , Interleukins/isolation & purification , Molecular Sequence Data , Molecular Weight
SELECTION OF CITATIONS
SEARCH DETAIL
...